Zhejiang East-Asia Pharmaceutical Co.,Ltd.’s Net Profit Rose 40.1% in First Three Quarters of 2023

Zhejiang East-Asia Pharmaceutical Co.,Ltd. (浙江东亚药业股份有限公司) (605177.SH) reported a net profit of 85.6 million yuan in the first three quarters of 2023, up 40.1% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, up 17.6% year-on-year.

At the end of the reporting period, it had 3.4 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 39.4%.